Heart Retransplantation to Treat a Case of Refractory Cardiac Allograft Vasculopathy / 대한내과학회지
Korean Journal of Medicine
; : 287-291, 2016.
Article
en En
| WPRIM
| ID: wpr-20331
Biblioteca responsable:
WPRO
ABSTRACT
Cardiac allograft vasculopathy is one of the most important causes of poor long-term survival after heart transplantation. The condition tends to be diffuse, usually affecting the mid-to-distal portions of the coronary artery. Reperfusion therapy is ineffective. Everolimus, an inhibitor of proliferation signaling, has been reported to prevent development of the condition; however, the efficacy thereof has not yet been fully accepted. The only definitive treatment for cardiac allograft vasculopathy is retransplantation. Herein, we describe the case of a 15-year-old boy who underwent heart retransplantation because of rapidly progressive cardiac allograft vasculopathy.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Reperfusión
/
Trasplante de Corazón
/
Vasos Coronarios
/
Aloinjertos
/
Everolimus
/
Corazón
Límite:
Adolescent
/
Humans
/
Male
Idioma:
En
Revista:
Korean Journal of Medicine
Año:
2016
Tipo del documento:
Article